Organoids predict clinical responses to treatment. The HUB Organoid Technology allows us to establish patient derived in vitro models of the most healthy and di...
Hubrecht Organoid Technology
Hubrecht Organoid Technology or HUB is a non-profit company that is founded around the Organoid Technology. The technology is based on the discovery of the LGR5 positive adult epithelial stem cell, first identified in the intestine in the group of Prof Dr Hans Clevers. After this discovery, the lab of Dr Clevers developed a method to genetically stable expand the stem cells into organoid structures that functionally mimic the patients original healthy or diseased epithelium. HUB collaborates with many partners such as pharma industry to improve preclinical drug development and provide more effective clinical treatment of patient using organoids as a predictive diagnostic tool.
Latest publications and upcoming events
- HUB and Yamaha Motor Announce their Collaboration Combi... April 10, 2019
- Hubrecht Organoid Technology and Crownbio announce stra... April 09, 2019
- HUB and AstraZeneca in joint presentation at Minipig Re... May 17, 2019
- Organoid course at MDIBL from May 26 to June 1 April 10, 2019